Scarica l'app Stockscreener
36.01
0.25%
-0.09
Dopo l'orario di chiusura:
36.02
0.01
+0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Vestor Capital LLC Buys New Shares in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
What analysts say about Royalty Pharma plc stockDynamic investment opportunities - Autocar Professional
Is Royalty Pharma plc a good long term investmentTriple-digit returns - jammulinksnews.com
What drives Royalty Pharma plc stock pricePhenomenal wealth increase - Autocar Professional
Royalty Pharma plc Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com
Edgestream Partners L.P. Purchases New Shares in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Citigroup Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price - MarketBeat
Citigroup maintains Buy rating, raises PT for Royalty Pharma to $42. - AInvest
Citi raises Royalty Pharma stock price target to $42 on CF and Tremfya growth - Investing.com UK
Royalty Pharma (RPRX) PT Raised to $42 at Citi - StreetInsider
C WorldWide Group Holding A S Acquires New Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Los Angeles Capital Management LLC Grows Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Stake Raised by Victory Capital Management Inc. - MarketBeat
Morgan Stanley Raises Royalty Pharma (RPRX) Price Target, Maintains Overweight Rating - MSN
Cullen Frost Bankers Inc. Acquires 247,903 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week HighTime to Buy? - MarketBeat
Royalty Pharma Declares Q3 2025 Dividend of $0.22 per Class A Share - AInvest
Royalty Pharma Declares Q3 2025 Dividend of $0.22 per Class A Ordinary Share - AInvest
Royalty Pharma PLC Announces Quarterly Dividend of $0.22 (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Declares Third Quarter 2025 Dividend - The Globe and Mail
Royalty Pharma announces $0.22 per share dividend for Q3 2025 - Investing.com
Royalty Pharma plc (RPRX) Declares $0.22 Quarterly Dividend; 2.5% Yield - StreetInsider
Royalty Pharma Announces Q3 2025 Dividend of $0.22 per Share - AInvest
How to Take Advantage of moves in (RPRX) - news.stocktradersdaily.com
Bryn Mawr Capital Management LLC Boosts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma plc stock a good hedge against inflationHigh Potential Safe Trades - Newser
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman To Board - citybiz
Royalty Pharma adds two independent directors to board By Investing.com - Investing.com India
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors - The Manila Times
Royalty Pharma adds two independent directors to board - Investing.com
Royalty Pharma Appoints Two New Independent Directors, Boosting Independent Board Representation to Over 90% - Quiver Quantitative
Royalty Pharma Appoints Denali CMO and Warburg Pincus Veteran to Board Following Major Acquisition - Stock Titan
Strata Wealth Advisors LLC Invests $387,000 in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Cerity Partners LLC Increases Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Has $45.53 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times
Royalty Pharma Q2 2025 Earnings Call: Key Details for August 6 Pre-Market Release - Stock Titan
4.91%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):